Trial Profile
Effect of sorafenib for hepatocellualr carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 13 May 2016 New trial record
- 17 Apr 2016 Results (n=12) assessing the complete response and dermatological adverse events presented at The International Liver Congress™ 2016